Portfolio

Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eyes, two chronic, common and debilitating disorders, with limited treatment options.

The SXT100 is the only commercial, lab-based solution for imaging subcellular structure. No other high resolution imaging modality is capable of quantitatively imaging the subcellular organization of whole hydrated cells, up to 15μm thick at resolutions up to 40 nm, in their native state, with very little preparation and without the use of stains or other contrast enhancing agents.

Developing tools to ensure everyone has bespoke access to gaming and the digital world.

Cinclus Pharma is a Swedish clinical-stage pharma company developing small molecules for the treatment of gastric acid-related diseases. Our lead candidate linaprazan glurate is being developed for the treatment of moderate to severe gastroesophageal reflux disease (GERD).

OncoAssure is a medical diagnostics company that identifies, develops, and commercialises clinically important biomarkers to significantly improve cancer management and treatment.

Developing an innovative drainage technology to treat malignant pleural effusions (MPE)

DermView’s technology enables patients, hospitals and clinics to receive rapid, accurate diagnosis from leading Mohs1 surgeons, consultant dermatologists and plastic surgeons. It provides Ireland’s fastest route to access a Consultant Dermatologist diagnosis.

Remote patient monitoring (RPM) for patients at risk of diabetic foot disease. Thermal and visual assessment in a single scan. Award winning, patented design.

Ovagen is a biotechnology company that has developed a proprietary process of producing Germ Free chicken eggs and Germ Free birds in commercial quantities for use primarily in the vaccine and pharmaceutical industry.

Sigrid Therapeutics is a clinical-stage biotechnology company pioneering a new class of therapies to prevent and treat lifestyle diseases.